Export

ATC codes: J05AF05
EMLc
Indication
Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified ICD11 code: 1C62.Z
INN
Lamivudine
Medicine type
Chemical agent
List type
Core
Formulations
Oral > Liquid: 50 mg per 5 mL (EMLc)
Oral > Solid: 150 mg tablet
EML status history
First added in 2002 (TRS 914)
Changed in 2007 (TRS 950)
Changed in 2017 (TRS 1006)
Sex
All
Age
Also recommended for children
Therapeutic equivalence
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Wikipedia
DrugBank
Summary of evidence and Expert Committee recommendations
Noting the advice from the WHO Department of HIV/AIDS about the continued recommendation in current WHO guidelines for use of lamivudine oral liquid for the treatment of newborns, the Expert Committee recommended that it be deleted from the EML but retained on the EMLc.